In an effort to strengthen its active pharmaceutical ingredients (API) business, RPG Life Sciences Ltd has agreed to transfer its Active Pharmaceutical Ingredients (API) business to RPG Active Pharma ...

Imported generic drugs could face tariffs of up to 100% beginning in 2028 under a plan announced Tuesday by President Trump, who said the measure is intended to push manufacturers to move production ...

The most common prescription drugs you pick up at the pharmacy counter or fill via mail order will likely get more expensive under President Donald Trump's plan to assess a 100% tariff on imported ...

Imported generic drugs will face a 100 percent tariff beginning in August 2028 unless manufacturers move production to the U.S., President Trump said in a social media post Tuesday. Trump wrote on ...

Trump said generic drugs imported into the U.S. will face zero tariffs for two years from August 1. The rate will rise to 100% in 2028, before doubling a year later. The latest tariff salvo ...

President Donald Trump announced Tuesday that imported generic drugs will remain tariff-free for the next two years before facing steep new import duties, saying the move is designed to encourage ...

President Donald Trump on Tuesday announced a plan to impose a 100 percent tariff on generic drugs starting in August 2028 as part of a bid to push pharmaceutical production back to the United States.

A stepped tariff schedule targets generics only, preserving existing treatment for patented and innovative drugs while signaling punitive intent for firms that do not invest in U.S. plant and ...

All the Latest Game Footage and Images from Stack & Sort Pals Stack & Sort Pals is a fun and addictive puzzle game where you sort colorful blocks, each representing a cute animal, into perfectly ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Carley ...

ZURICH, June 29 (Reuters) - The U.S. Food and Drug Administration has agreed to review Swiss generics drugmaker Sandoz's (SDZ.S), opens new tab two generic tirzepatide GLP-1s that, ‌if approved, would ...